Leucadia Therapeutics
Company developing an early diagnostic and a device to prevent Alzheimer's disease
Leucadia Therapeutics Inc is privately-held, pre-clinical stage company focused on Alzheimer's disease prevention and treatment. The company is developing a diagnostic algorithm for Alzheimer's disease risk based on big data. A therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment(MCI) from progressing to Alzheimer's disease.
Visit website: https://www.leucadiatx.com/
Details last updated 04-May-2019
People at Leucadia Therapeutics
Leucadia Therapeutics News
Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Read more...Fight Aging! reports back from SENS Research Foundation Pitch Day
Fight Aging! - 20-Jan-2020
When some of these succeed in human trials even more money will pile in to fund further advances
Read more...Undoing Aging 2018: an initiative to remember
Long Long Life - 22-Mar-2018
45 speakers, scientists and entrepreneurs, presented their work. Attended by 350 people from a t...
Read more...
